Literature DB >> 11081172

The importance of locating a good pituitary surgeon.

J A Wass1, H E Turner, C B Adams.   

Abstract

Mesh：

Year:  1999        PMID： 11081172     DOI： 10.1023/a:1009982232672

Source DB:  PubMed          Journal:  Pituitary        ISSN： 1386-341X            Impact factor:   4.107


× No keyword cloud information.
  12 in total

1.  Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: initial outcome and long-term results.

Authors:  A Abosch; J B Tyrrell; K R Lamborn; L T Hannegan; C B Applebury; C B Wilson
Journal:  J Clin Endocrinol Metab       Date:  1998-10       Impact factor: 5.958

2.  Radiotherapy for non-function pituitary tumours.

Authors:  N J Gittoes; A S Bates; W Tse; B Bullivant; M C Sheppard; R N Clayton; P M Stewart
Journal:  Clin Endocrinol (Oxf)       Date:  1998-03       Impact factor: 3.478

Review 3.  The outcome of surgery for acromegaly: the need for a specialist pituitary surgeon for all types of growth hormone (GH) secreting adenoma.

Authors:  C A Lissett; S R Peacey; I Laing; L Tetlow; J R Davis; S M Shalet
Journal:  Clin Endocrinol (Oxf)       Date:  1998-11       Impact factor: 3.478

4.  Retrospective analysis of long-term surgical results in acromegaly: preoperative and postoperative factors predicting outcome.

Authors:  S Yamada; T Aiba; K Takada; Y Ozawa; T Shimizu; S Sawano; Y Shishiba; T Sano
Journal:  Clin Endocrinol (Oxf)       Date:  1996-09       Impact factor: 3.478

5.  Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group.

Authors:  S M Orme; R J McNally; R A Cartwright; P E Belchetz
Journal:  J Clin Endocrinol Metab       Date:  1998-08       Impact factor: 5.958

6.  An audit of outcome of treatment in acromegaly.

Authors:  A S Bates; W Van't Hoff; J M Jones; R N Clayton
Journal:  Q J Med       Date:  1993-05

7.  Determinants of clinical outcome and survival in acromegaly.

Authors:  C Rajasoorya; I M Holdaway; P Wrightson; D J Scott; H K Ibbertson
Journal:  Clin Endocrinol (Oxf)       Date:  1994-07       Impact factor: 3.478

8.  The Birmingham pituitary database: auditing the outcome of the treatment of acromegaly.

Authors:  D Jenkins; I O'Brien; A Johnson; R Shakespear; M C Sheppard; P M Stewart
Journal:  Clin Endocrinol (Oxf)       Date:  1995-11       Impact factor: 3.478

9.  Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly.

Authors:  B Swearingen; F G Barker; L Katznelson; B M Biller; S Grinspoon; A Klibanski; N Moayeri; P M Black; N T Zervas
Journal:  J Clin Endocrinol Metab       Date:  1998-10       Impact factor: 5.958

10.  Factors determining the long-term outcome of surgery for acromegaly.

Authors:  I A Osman; R A James; S Chatterjee; D Mathias; P Kendall-Taylor
Journal:  QJM       Date:  1994-10
View more
  8 in total

1.  Orbital decompression for Graves' orbitopathy in England.

Authors:  P Perros; T Chandler; C M Dayan; A J Dickinson; P Foley; J Hickey; C J Macewen; J H Lazarus; J McLaren; G E Rose; J M Uddin; B Vaidya
Journal:  Eye (Lond)       Date:  2011-12-09       Impact factor: 3.775

2.  The history of the treatment of pituitary adenomas.

Authors:  Nicholas F Maartens
Journal:  Endocrine       Date:  2005-10       Impact factor: 3.633

3.  Determinants of neurosurgical outcome in pituitary tumors.

Authors:  M J Barahona; L Sojo; A M Wägner; F Bartumeus; B Oliver; P Cano; S M Webb
Journal:  J Endocrinol Invest       Date:  2005-10       Impact factor: 4.256

Review 4.  Preoperative somatostatin analogues versus direct transsphenoidal surgery for newly-diagnosed acromegaly patients: a systematic review and meta-analysis using the GRADE system.

Authors:  V S Nunes; J M S Correa; M E S Puga; E M K Silva; C L Boguszewski
Journal:  Pituitary       Date:  2015-08       Impact factor: 4.107

5.  Surgical debulking of pituitary adenomas improves responsiveness to octreotide lar in the treatment of acromegaly.

Authors:  Rudolf Fahlbusch; David Kleinberg; Beverly Biller; Vivien Bonert; Michael Buchfelder; Paolo Cappabianca; John Carmichael; William Chandler; Annamaria Colao; Ajax George; Anne Klibanski; Edmond Knopp; Juergen Kreutzer; Neehar Kundurti; Martin Lesser; Adam Mamelak; Rosario Pivonello; Kalmon Post; Brooke Swearingen; Mary Lee Vance; Ariel Barkan
Journal:  Pituitary       Date:  2017-12       Impact factor: 4.107

Review 6.  The optimal numerosity of the referral population of pituitary tumors centers of excellence (PTCOE): A surgical perspective.

Authors:  Pietro Mortini; Gianluca Nocera; Francesca Roncelli; Marco Losa; Anna Maria Formenti; Andrea Giustina
Journal:  Rev Endocr Metab Disord       Date:  2020-12       Impact factor: 6.514

Review 7.  The postoperative monitoring of nonfunctioning pituitary adenomas.

Authors:  John A H Wass; Raghava Reddy; Niki Karavitaki
Journal:  Nat Rev Endocrinol       Date:  2011-04-05       Impact factor: 43.330

Review 8.  Medical Treatment with Somatostatin Analogues in Acromegaly: Position Statement.

Authors:  Sang Ouk Chin; Cheol Ryong Ku; Byung Joon Kim; Sung Woon Kim; Kyeong Hye Park; Kee Ho Song; Seungjoon Oh; Hyun Koo Yoon; Eun Jig Lee; Jung Min Lee; Jung Soo Lim; Jung Hee Kim; Kwang Joon Kim; Heung Yong Jin; Dae Jung Kim; Kyung Ae Lee; Seong Su Moon; Dong Jun Lim; Dong Yeob Shin; Se Hwa Kim; Min Jeong Kwon; Ha Young Kim; Jin Hwa Kim; Dong Sun Kim; Chong Hwa Kim
Journal:  Endocrinol Metab (Seoul)       Date:  2019-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.